Trials / Completed
CompletedNCT05032547
Primary Care Online Emotion-regulation Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Region Stockholm · Other Government
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
We will evaluate a transdiagnostic digital emotion regulation treatment for youth with mental health problems.
Detailed description
Mental health problems in youth are a global problem, causing incalculable suffering in youth and families, harming long-term prospects of youths, and are creating substantial economic costs to society. Existing treatments are not fully addressing these problems because they focus on a subset of mental health problems; they are limited in efficacy; and are not provided to most youth in need. Transdiagnostic digital treatments that address mechanisms underlying mental health problems, such as emotion regulation, have been called for to address these problems. As an initial pilot study we will include 60 participants aged 12-17 years and their parents in a randomized controlled feasibility trial comparing a 6-week Primary care Online Emotion-regulation Treatment (POET) to a 6-week active Supportive Treatment (ST). Both interventions will be delivered in blended format combining online therapist-supported treatment modules with a video-link session. The primary study aims are to examine the feasibility and acceptability of study protocol and treatment protocols. Preliminary utility of the experimental condition will be evaluated by youth-reported, parent-reported, and clinical-reported outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Therapist-supported digitally delivered transdiagnostic emotion regulation treatment | Please see description of experimental arm (arm one) |
| BEHAVIORAL | Therapist-supported digitally delivered supportive treatment | Please see description of active comparator arm (arm two) |
Timeline
- Start date
- 2022-10-16
- Primary completion
- 2023-02-24
- Completion
- 2023-06-06
- First posted
- 2021-09-02
- Last updated
- 2024-01-10
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05032547. Inclusion in this directory is not an endorsement.